Homburger

On August 5, 2025, UBS Group AG successfully completed its offering of USD 1,250,000,000 in aggregate principal amount of 7.000 per cent. Tier 1 Capital Notes and USD 750,000,000 in aggregate principal amount of 6.600 per cent. Tier 1 Capital Notes. The Notes are «high trigger» regulatory capital instruments that are eligible to fulfill UBS Group AG’s Swiss going concern requirements. Upon occurrence of a «Trigger Event» or a «Viability Event», the Notes will be converted into ordinary shares of UBS Group AG in accordance with their terms. The Notes are governed by Swiss law and have been admitted to trading and are listed on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Olivier Baum (both Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

Homburger acted as counsel to Swarovski International Holding AG and its Subsidiaries in connection with an up to EUR 550 m financing, with UBS Switzerland AG as Coordinating and Bookrunning Mandated Lead Arranger, Facility Agent and Security Agent and BNP PARIBAS, Paris, Lancy/Geneva Branch and Zürcher Kantonalbank as Coordinating and Bookrunning Mandated Lead Arrangers as well as an international and Swiss syndicate of banks as Lenders. Homburger advised Swarovski with regard to all Swiss legal aspects of the financing transaction. The Homburger team was led by Jürg Frick (Financing and Investment Products) and included Nathalie Scherrer and Sarah Fasel (both Financing) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

Homburger acted as counsel to UBS Switzerland AG as mandated lead arranger, agent, security agent and original lender in connection with the financing of the acquisition of a majority stake in Horizon Home Care Group AG, a Swiss-based international provider of non-medical home care services operating under the brand Dovida, by Ardian. Dovida provides person-centered non-medical home care which is carefully designed to support, empower and uplift individuals, and enhance their quality of life. Dovida’s global footprint spans six countries (Australia, Ireland, France, Netherlands, New Zealand, and Switzerland) delivering nine million hours of care each year. With a global presence and a local touch, Dovida delivers care that’s personal, empowering, and impactful. Homburger advised UBS Switzerland AG with regard to all Swiss legal aspects of the financing transaction. The Homburger team was led by Jürg Frick and included Stefan Bindschedler, Nathalie Scherrer and Sarah Fasel (all Financing) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On June 2, 2025, the German vehicle inspection company DEKRA SE announced the acquisition of an additional stake in Spearhead AG, a Swiss company specializing in data analytics for automotive claims and vehicle lifecycle management. As a result of the transaction, DEKRA SE became the majority shareholder of Spearhead AG. Homburger acted as legal counsel to DEKRA SE. Gregor Bühler (IP / IT) led the Homburger team, which included Romain Fakhoury-Hondius (Corporate / M&A) and Philippe Baumann (IP / IT). Contact Nanding Susso / Marketing / [email protected]

On June 30, 2025, Yoda PLC, a Cyprus-based investment corporation listed on the Cyprus stock exchange (CSE: YODA), announced the completion of its investment into ULTIMA CAPITAL SA, a Swiss luxury real estate owner, developer and operator listed on BX Swiss (BX: ULTIMA). As part of the transaction, Yoda has transferred to Ultima, by way of a contribution in kind, 100% of the issued share capital of its wholly-owned subsidiary Bakaso Holdings Limited at a contribution value of CHF 120.0 m in exchange for 2,000,000 newly-issued shares in Ultima. Bakaso indirectly owns various commercial properties valued at approximately EUR 133.7 m primarily in the food and beverage and retail sector located in the areas of Psarrou and Ano Mera, Mykonos, Greece, including the Nammos beach-bar restaurant and the seven-building Nammos Village retail area. As a result of the transaction, Yoda increased its shareholding in Ultima from previously approximately 53.8% to approximately 64.0% post-completion. Homburger advised Yoda on all aspects of the transaction. The Homburger team was led by Lorenzo Togni and included Jonas Stähli and Viviane Egli (all Corporate / M&A) as well as Claudia Suter and Philippe Weber (both Tax). Stefan Blunschi and Micha Frankhauser (both Corporate / M&A) also contributed to the transaction. Contact Nanding Susso / Marketing / [email protected]

On June 25, 2025, Idorsia Ltd published its public repurchase offer (the Exchange Offer) to exchange its CHF 200 m senior unsecured convertible bonds due 2025 and its CHF 600 m senior unsecured convertible bonds due 2028 (the Bonds). The Bonds will be exchanged for an offer consideration consisting of (i) a series of newly issued „Pay-If-You-Can“ notes with waterfall rankings issued by a Luxembourg special purpose subsidiary, which will be listed on the International Stock Exchange, (ii) shares of Idorsia Ltd and (iii) warrants of Idorsia Ltd. The Swiss Takeover Board has made determinations and granted exemptions regarding the Exchange Offer in its ruling dated June 5, 2025. The Exchange Offer is part of the holistic restructuring and refinancing of the Idorsia group announced by Idorsia Ltd on February 26, 2025. The Homburger team was led by Frank Gerhard (Corporate / M&A, Capital Markets) and included Marco Rostetter (Corporate / M&A, Restructuring / Insolvency), Micha Fankhauser, Estelle Piccard and Anina Preusker (all Corporate / M&A) as well as Eduard De Zordi and Daniel Hulmann (both Capital Markets). Contact Johanna Schmid / Marketing / [email protected]

On June 19, 2025, Julius Baer Group Ltd. issued EUR 500 m notes (the Notes). The issuance occurred indirectly through the ELM issuance vehicle, a repackaging issuance entity incorporated in the Netherlands. The Notes will be listed on Euronext Dublin. For the Notes, UBS AG, London Branch, BNP PARIBAS, Citigroup Global Markets Europe AG and J.P. Morgan SE acted as Joint Lead Managers. The Homburger team was led by Benjamin Leisinger and Eduard De Zordi (both Capital Markets). Tax aspects were covered by Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On May 27, 2025, BeOne Medicines Ltd., a global oncology company, officially completed its redomiciliation from the Cayman Islands to Basel, Switzerland, following shareholder approval on April 28, 2025. The redomiciliation to Switzerland strengthens BeOne’s presence and deepens its roots in a global biopharmaceutical hub, further enabling its growth strategy of bringing innovative medicines to patients around the world. BeOne Medicines Ltd.'s American Depositary Shares are listed on the Nasdaq Global Select Market, each representing 13 ordinary shares of BeOne Medicines Ltd., each having a par value of USD 0.0001 per share (the “Ordinary Shares”), the Ordinary Shares are listed on The Stock Exchange of Hong Kong Limited, and the Ordinary Shares traded in Renminbi are listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange. The Homburger team was led by David Oser (Corporate / M&A, Capital Markets) and included Bianca Nedwed and Kaiyan Yeo (both Corporate / M&A, Capital Markets), Stefan Bindschedler and Benjamin Leisinger (Banking and Finance) as well as Stefan Oesterhelt and Juliette Buob (both Tax). Contact Johanna Schmid / Marketing / [email protected]

On June 18, 2025, EFG Bank AG successfully completed its issuance of CHF 125 m 0.9625% bonds 2025 – 2029. Raiffeisen Schweiz Genossenschaft acted as Sole Lead Manager. Homburger acted as counsel to Raiffeisen Schweiz Genossenschaft. The Homburger team was led by Benjamin Leisinger and included Olivier Baum (both Capital Markets). Contact Wanda Schweda / Marketing / [email protected]

On June 12, 2024, ADC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced the private placement of 13.0 m common shares and pre-funded warrants to purchase 15.7 m common shares, raising aggregate gross proceeds of USD 100 m. The Homburger team was led by Daniel Häusermann (Corporate / M&A, Capital Markets) and included Bianca Nedwed and Estelle Piccard (both Corporate / M&A, Capital Markets) as well as Stefan Oesterhelt and Philippe Weber (both Tax). Contact Wanda Schweda / Marketing / [email protected]

On February 28, 2025, the Court of Arbitration of SIX Group AG issued a precedent-setting award, finding that Clariant AG had published the ad hoc announcement concerning the financial reporting matters under investigation in winter 2021/22 in a timely manner. As a result, the tribunal annulled the fine previously imposed by the Sanctions Commission of SIX Group AG in this respect. For the first time, the tribunal provided guidance on the ad hoc disclosure threshold in the context of internal investigations and upheld Clariant’s position that the Listing Rules of SIX Exchange Regulation AG protect an issuer’s duly exercised discretion in deciding whether to issue an ad hoc announcement. In relation to a negligent violation of the ad hoc disclosure regulations concerning the publication of the 2021 Integrated Report, the tribunal imposed a reduced fine of CHF 100,000 for not labeling the announcement as an ad hoc announcement («flagging»). This seminal decision largely overturns an earlier decision by the Sanctions Commission, which had found that Clariant AG grossly negligently violated the ad hoc disclosure regulations by publishing the February 14, 2022 announcement concerning the ongoing investigation too late, and by not labeling the 2021 Integrated Report via an ad hoc announcement. The Sanctions Commission had imposed a total fine of CHF 500,000 on Clariant AG. Clariant AG challenged the Sanctions Commission's decision by initiating arbitration proceedings before the SIX Court of Arbitration. The arbitral award is final and legally binding. It marks the first time that an issuer prevails in arbitration proceedings against SIX Exchange Regulation AG in an ad hoc disclosure matter. The Homburger team comprised Frank Gerhard (Corporate / M&A, Capital Markets), Mariella Orelli (Litigation, Arbitration), Micha Fankhauser (Corporate / M&A, Capital Markets) and Richard G. Allemann (Litigation, Arbitration).   Contact Johanna Schmid / Marketing / [email protected]

On June 2, 2025, Temenos announced that it has completed the sale of Multifonds, its fund administration software business, to Montagu Private Equity. The Homburger team was led by Dieter Gericke and Daniel Häusermann (both Corporate / M&A) and included Nicola Togni, Romain Hondius, Thomas Romelli, Luca Ellenberger, Miriam Oelgarth and Myriam Amman-Jerdak (all Corporate / M&A), Gregor Bühler, Philippe Baumann and Kristina Martinovic (all IP / IT), Stefan Oesterhelt, Laetitia Fracheboud and Juliette Buob (all Tax) as well as Richard Stäuber and Christoph Grüninger (both Competition). Contact Johanna Schmid / Marketing / [email protected]

On February 10, 2025, UBS Group AG successfully completed its offering of USD 1,500,000,000 in aggregate principal amount of 7.125 per cent. Tier 1 Capital Notes and USD 1,500,000,000 in aggregate principal amount of 7.000 per cent. Tier 1 Capital Notes. The Notes are "high trigger" regulatory capital instruments that are eligible to fulfill UBS Group AG’s Swiss going concern requirements. Upon occurrence of a "Trigger Event" or a "Viability Event", the Notes will be converted into ordinary shares of UBS Group AG in accordance with their terms. The Notes are governed by Swiss law and have been admitted to trading and are listed on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets), Claude Lambert (Corporate / M&A), as well as Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On May 9, 2025, UBS Group AG successfully completed its issuance of USD 1.75 bn in aggregate principal amount of Fixed Rate/Floating Rate Callable Senior Notes due May 2036 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG's Swiss gone concern requirement. The Notes are governed by Swiss law and the Notes have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On May 12, 2025, UBS Group AG successfully completed its issuance of EUR 1.25 bn in aggregate principal amount of Floating Rate Callable Senior Notes due 2029 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG's Swiss gone concern requirement. The Notes are governed by Swiss law and the Notes have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On February 12, 2025, UBS Group AG successfully completed its issuance of EUR 1.5 bn in aggregate principal amount of 3.250 per cent. Fixed Rate/Fixed Rate Callable Senior Notes due February 2034 and EUR 1.25 bn in aggregate principal amount of 2.875 per cent. Fixed Rate/Fixed Rate Callable Senior Notes due February 2030 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG's Swiss gone concern requirement. The Notes are governed by Swiss law and the Notes have been admitted to trading and are listed on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On February 27, 2025, BIOTRONIK Group announced that it has entered into an agreement to divest its Vascular Intervention (VI) business division to Teleflex Incorporated. The transaction is subject to regulatory approvals and other customary closing conditions and is expected to close before the end of the third quarter of 2025. BIOTRONIK is a Berlin-based global leader in medical technology and a pioneer in cardiovascular, endovascular, and neuromodulation solutions. Teleflex (NYSE: TFX) is a Pennsylvania-based leading global provider of medical technologies with a diverse portfolio, including solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Homburger acts as Swiss transaction counsel to BIOTRONIK. The team includes Andreas Müller, Anna Peter, Jasmin Künzle, Romain Hondius, Oliver Kneubühl and Cédric Berger (all Corporate / M&A), Richard Stäuber and Angelika Murer (both Regulatory), Luca Dal Molin and Philippe Baumann (both IP / IT), Stefan Gäumann (Real Estate), Jeremy Reichlin and Angela Casey (both Employment and Executive Compensation), as well as Reto Heuberger and Philippe Weber (both Tax). Contact Beatrice Winkler / Marketing / [email protected]

Zurich Airport Ltd. announced on May 12, 2025, its acquisition of full ownership of the Radisson Blu Building at Zurich Airport from Al Maha Real Estate AG. The acquisition was executed through an early reversion of the building right for a purchase price of approximately CHF 155 m. This strategic transaction offers new development opportunities for Zurich Airport Ltd. within the central airport perimeter. The Homburger team included Andreas Müller (Corporate / M&A), Reto Heuberger and Laetitia Fracheboud (both Tax) as well as Olivier Bühlmann (Real Estate). Contact Johanna Schmid / Marketing / [email protected]  

On May 23, 2025, Dufry One B.V. issued EUR 500 m 4.50% Senior Notes due 2032 guaranteed by Avolta AG and certain of its subsidiaries. Banca Akros SpA, BNP Paribas, ING Bank N.V., Landesbank Baden-Württemberg, Banco Santander S.A. and UBS AG London Branch acted as joint global coordinators and joint bookrunners. Bank of China Limited, London Branch, Banco Bilbao Vizcaya Argentaria, S.A., BofA Securities Europe S.A., Commerzbank Aktiengesellschaft, Crédit Agricole Corporate and Investment Bank, Crédit Industriel et Commercial S.A., Goldman Sachs Bank Europe SE, HSBC Continental Europe, Intesa Sanpaolo S.p.A., Mediobanca Banca di Credito Finanziario SpA, MUFG Securities (Europe) N.V., Raiffeisen Bank International AG and UniCredit Bank GmbH acted as joint bookrunners and Raiffeisen Schweiz Genossenschaft and DZ BANK AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main acted as co-managers. The Homburger team comprised Andreas Müller (Capital Markets), Jürg Frick and Daniel Hulmann (both Capital Markets) as well as Dieter Grünblatt (Tax). Contact Nanding Susso / Marketing / [email protected]

On May 27, 2025, a consortium led by EQT, consisting of Sunshine SwissCo GmbH, the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as the Sellers), announced the launch of an accelerated bookbuilding process to professional investors in Switzerland and to qualified investors outside Switzerland, which led to the successful placement of 19,031,811 shares in Galderma Group AG (Galderma) at a price of CHF 97.75 per share (the Placement), raising a total of ca. CHF 1,860 m in total. Galderma participated in the Placement by agreeing to repurchase 2,378,976 shares for a total consideration of ca. CHF 233 m, at the same price per share determined by the bookbuilding process. The Sellers will remain shareholders of 40.2% of the share capital of Galderma. EQT’s representation on the board of directors of Galderma remains unchanged as a result of the Placement. Such Placement will broaden Galderma's shareholder base and free float. In connection therewith, the Sellers have agreed to a 90-day lock-up period, subject to certain customary exceptions, with respect to their remaining holding in Galderma. The Placement is expected to be settled on June 2, 2025. Following the Placement, no changes to the Galderma board of directors and its governance are envisioned. Homburger acted as transaction counsel to EQT. The Homburger team was led by Frank Gerhard (Corporate / M&A, Capital Markets) and included Margrit Marti, Estelle Piccard, Héloïse de Jamblinne and Lucas Forrer (all Corporate / M&A, Capital Markets), Micha Fankhauser (Financial Market Regulation) as well as Stefan Oesterhelt (Tax). Contact Nanding Susso / Marketing / [email protected]